FDA Warns Prominent Firms Against Marketing and Selling ‘Unapproved’ Eye Products

The FDA advised consumers who use eye products mentioned in the latest warning letters to consult with their doctor.

The U.S. Food and Drug Administration (FDA) in White Oak, Md., on June 5, 2023. Madalina Vasiliu/The Epoch Times

The U.S. Food and Drug Administration (FDA) issued warning letters to eight companies for manufacturing or selling unapproved eye products, which the agency says is “in violation of federal law.”

The warning letters cited concerns about eye products manufactured by the firms which are “illegally marketed” to treat multiple conditions like conjunctivitis or “pink eye,” cataracts, and glaucoma, among other ailments, the agency said in a Sept. 12 statement.